Search results
Found 447 matches for
The first-ever MQPH Conference will take place at Keble College, Oxford on 23-28 September 2018. This international event will bring together people from public health, national regulatory authorities, pharmacy, biomedical, chemistry, law, ethics, cultural and social sciences, pharmaceutical industry, international organisations and NGOs. It grants an opportunity to discuss the problem and outline the necessary steps to tackle the issue on a global scale.
Real-time genetic surveillance can support timely, evidence-based responses to shifting malaria threats
25 June 2025
A sharp decline in piperaquine-resistant strains of P. Falciparum malaria following drug policy revisions across the Greater Mekong Subregion (GMS) highlights how real-time genetic data can support timely, evidence-based responses to shifting malaria threats, say researchers in a study published in Nature Communications.
Landmark DeTACT project holds final Investigators’ meeting
26 May 2025
On 6-7 May in Zanzibar, Tanzania, the final investigators’ meeting of the Development of Triple Artemisinin-based Combination Therapies (DeTACT) project brought together 35 investigators from participating institutions in Bangladesh, Cambodia, Guinea, Nigeria, Niger, Tanzania, The Gambia, Rwanda, Singapore, and MORU, along with key partners from Fosun Pharma, Medicines for Malaria Venture (MMV), the WHO Global Malaria Programme, and the UK Foreign, Commonwealth and Development Office (FCDO), which funded the project over the past seven years.
Building Better Vaccines: Dr Thitinan Kitisin Explores Tonsil Organoids Models in Thailand
23 April 2025
Years of groundwork have led Mahidol University Assistant Professor Dr Thitinan Kitisin to his first major step: leading an advanced vaccine research project in Thailand. With support from MODRA, he’s now developing one of the first tonsil organoid models in the country, a small but important step toward improving how vaccines are tested. Along the way, he’s also passing on practical research skills to the next generation of Thai scientists.
MORU-Oxford Engagement Meeting
8 April 2025
On 27 March, members of the Public and Community Engagement with Research (PCER) team at the University of Oxford met with MORU colleagues and other engagement colleagues from the University. The session focused on sharing strategies for community engagement, evaluating engagement, and exploring opportunities for future collaboration.
Blog: From post-PhD uncertainty to leading international research
4 April 2025
Dr Duong Thi Hue Kien, a Post-doc Scientist at OUCRU, has shared her experience of finishing her PhD and kickstarting her career in science. She documents the highs and the lows, as well as how she was able to move forward in her career with support from MODRA, the MORU–OUCRU Discovery Research Academy.
MORU hosts international workshop on safer drug use in obstetric and paediatric medicine through PBPK modelling
19 March 2025
Healthcare professionals, researchers, and policymakers gathered in Bangkok 12-13 March for PBPK modelling in paediatrics, pregnancy and lactation, a major international workshop addressing a longstanding issue in medicine: ensuring safer and more effective drug treatments for pregnant or lactating women and children.
Workshop seeks to strengthen pandemic preparedness in SE Asia
14 March 2025
From 18-19 Feb, SEACOVARIANTs project public engagement team members from Thailand, Viet Nam and Indonesia hosted a workshop, Southeast Asia Social, Ethical, and Engagement Aspects of Pandemic Preparedness, in Da Nang, Viet Nam.
Innovative forensics to identify origins of falsified medicines presented to UNODC and WHO
11 March 2025
On 24-26 Feb 2025, Paul Newton, Head of MORU’s Medicine Quality Research Group (MQRG), and MQRG Deputy Head Céline Caillet presented work by the MQRG at the UN Office on Drugs and Crime (UNODC) and WHO meeting, Strategic and Tactical Interventions to Address Medical Products-Related Crimes.
Bangladesh malaria mass vaccine and drug administration trial begins
19 February 2025
After more than a year of community engagement and preparation in 100 villages with 12,000 populations across the Chittagong Hill Tracts, the mass malaria vaccine (R21/Matrix M) and drug (DHA, piperaquine, and single low dose primaquine) administration study started on 15 Feb.
Identifying fake Covid-19 vaccines by analysing vial labels and vaccine liquids
31 January 2025
Researchers at MORU's Medicine Quality Research Group (MQRG), University of Oxford and collaborators, including the Serum Institute of India, have published an innovative method to identify falsified vaccines without opening the vaccine vial.
Study finds methaemoglobin levels could predict malaria recurrence
26 November 2024
A new study has found methaemoglobin levels during treatment for vivax malaria could be used to predict whether a patient would have recurrent malaria.
MODRA Workshop 2 empowers next generation of researchers
19 November 2024
The MORU-OUCRU Discovery Research Academy (MODRA) Workshop 2 was recently held in Ho Chi Minh City, Vietnam.
The Medicine Quality Research Group invited to present at the World Health Summit, Berlin, 15th October
6 November 2024
Dr Gesa Gnegel and Dr Céline Caillet were invited to present their current work during a session at the World Health Summit. This international forum and leading global health conference brings together stakeholders from politics, science, the private sector, and civil society. The aim of this event that took place in Berlin from the 13th to the 15th of October 2024 is ‘to set the agenda for a healthier future by inspiring innovative solutions for better health and well-being for all’.
Innovative diagnostics, new tools, near-elimination strategies, cross-border collaborations top agenda at malaria elimination joint meeting
1 November 2024
From 24-26 Sept, the Asia Pacific Malaria Elimination Network (APMEN) Vivax Working Group (VxWG) and Surveillance & Response Working Group (SRWG) held their 2024 Joint Annual Meeting in Kuching, Malaysia. Co-organized by SRWG and VxWG host institutions MORU and Medicines for Malaria Venture (MMV), the event took place immediately following the 2024 International Congress for Tropical Medicine and Malaria (ICTMM).
Dr Claire Chewapreecha wins Nature Award for Inspiring Women in Science
1 November 2024
Dr Chewapreecha, a Wellcome International Intermediate Fellow and computational biologist at NDM's Mahidol-Oxford Tropical Medicine Research Unit, has been announced as the Individual Winner at this year’s Inspiring Women in Science Awards hosted by Nature and The Estée Lauder Companies. She was honoured at a ceremony in London on 31 October.
Experts gather to discuss medicine quality research
1 November 2024
Experts from across Europe joined forces to discuss research on substandard and falsified medical products and how to translate the evidence into policy and implementation. Over forty participants from various countries around the world, all based in Europe, including the UK, Sweden, France, Germany and Belgium, joined the in-person informal event at the Richard Doll Building, in Oxford, on the 24th of October.
Lorenz von Seidlein awarded RSTMH medal for outstanding work in tropical health
29 October 2024
On 10 Oct in London, the Royal Society for Tropical Medicine and Hygiene (RSTMH) awarded MORU’s Prof Lorenz von Seidlein (centre) the Donald Mackay Medal for outstanding work in tropical health, especially relating to improvements in the health of rural or urban workers in the tropics.
MODRA Workshop Empowers Early-Career Scientists to Secure Competitive Research Grants
7 October 2024
The MORU-OUCRU Discovery Research Academy (MODRA) recently concluded its inaugural workshop in Bangkok. This intensive five-day programme equipped 15 promising postdoctoral researchers with the skills required to complete a high-quality seed proposal.
New study to support WHO guideline changes
2 October 2024
A new study which will help inform World Health Organization guidelines for treating children with Plasmodium vivax malaria has found that giving children higher doses of primaquine substantially reduced recurrences of malaria.
FORESFA collaborators discuss organised crime groups, AI and public health impact of SF medicines at annual meeting
20 September 2024
From 4-6 Sept, nearly 40 Forensic Epidemiology and impact of Substandard and Falsified Antimicrobials (FORESFA) project collaborators from 10 different countries met at Jesus College, Oxford, to share updates and make final year plans.